Zhengye Biotechnology (ZYBT) Stock Price, News & Analysis

Company Overview

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Key Stats

• Today's Range: $0.71 to $0.75
• 50-Day Range: $0.71 to $1.03
• 52-Week Range: $0.68 to $13.08
• Volume: 15,935 shs
• Average Volume: 190,442 shs
• Market Capitalization: $33.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Zhengye Biotechnology Stock Analysis - MarketRank™

Zhengye Biotechnology scored higher than 13% of companies evaluated by MarketBeat, and ranked 814th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Zhengye Biotechnology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Zhengye Biotechnology has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Zhengye Biotechnology has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.23% of the float of Zhengye Biotechnology has been sold short.

Short Interest Ratio / Days to Cover

Zhengye Biotechnology has a short interest ratio ("days to cover") of 0.33, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Zhengye Biotechnology has recently increased by 265.53%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zhengye Biotechnology does not currently pay a dividend.

Dividend Growth

Zhengye Biotechnology does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.43

News Sentiment

Zhengye Biotechnology has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Zhengye Biotechnology this week, compared to 1 article on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Zhengye Biotechnology insiders have not sold or bought any company stock.

Percentage Held by Institutions

Zhengye Biotechnology has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 4/28/2026
• Today: 6/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ZYBT
• Previous Symbol: NASDAQ:ZYBT
• CIK: 1975641
• Web: www.jlzybio.com
• Phone: 86-13844801919
• Fax: N/A
• Employees: 278
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 1.14
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $16.64 million
• Price / Sales: 2.03
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.93 per share
• Price / Book: 0.77

Miscellaneous

• Outstanding Shares: 47,390,000
• Free Float: N/A
• Market Cap: $33.81 million
• Optionable: N/A
• Beta: -2.40